Patent assignee · BE · COMPANY

Ablynx N.V.

163Patents
162Active
163Granted
57Portfolio score

Filing activity: Jan 9, 2004 → Jun 27, 2022 · 29 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8188223B2 Serum albumin binding proteins Chemistry; Metallurgy 52 Active
US7807162B2 Single domain VHH antibodies against von Willebrand factor Emerging Cross-Sectional Technologies 48 Active
US8557965B2 Single variable domains against notch pathway members Chemistry; Metallurgy 43 Active
US8629244B2 Interleukin-6 receptor binding polypeptides Chemistry; Metallurgy 42 Active
US8703135B2 Biological materials related to c-Met Chemistry; Metallurgy 34 Active
US8937164B2 Biological materials related to CXCR7 Chemistry; Metallurgy 32 Active
US8975382B2 Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumors Chemistry; Metallurgy 26 Active
US8907065B2 Polypeptides that modulate the interaction between cells of the immune system Chemistry; Metallurgy 26 Active
US8962807B2 Single variable domain antibodies against OX40L, constructs and therapeutic use Emerging Cross-Sectional Technologies 24 Active
US8703131B2 Nanobodies against tumor necrosis factor-alpha Human Necessities 20 Active
US8623361B2 Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disorders Chemistry; Metallurgy 18 Active
US10927186B2 T cell recruiting polypeptides based on TCR alpha/beta reactivity Chemistry; Metallurgy 15 Active
US9745372B2 TNF binders Chemistry; Metallurgy 14 Active
US9193780B2 Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases Chemistry; Metallurgy 14 Active
US8748581B2 Anti-IL-6R polypeptides and pharmaceutical compositions thereof Chemistry; Metallurgy 13 Active
US8962805B2 Anti IL-6R polypeptides and compositions thereof Chemistry; Metallurgy 13 Active
US10544211B2 TNF binders Chemistry; Metallurgy 12 Active
US10858418B2 Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains Physics 12 Active
US9067991B2 Nanobodies against tumor necrosis factor-alpha Chemistry; Metallurgy 10 Active
US9273150B2 Methods of using IL-6R antibodies to block or reduce binding of IL-6 to IL-6R Chemistry; Metallurgy 10 Active
US9181350B2 Nucleic acids encoding IL-6R-binding polypeptides Chemistry; Metallurgy 10 Active
US11208476B2 Polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP Chemistry; Metallurgy 8 Active
US10968271B2 Polypeptides against IL-23 Chemistry; Metallurgy 8 Active
US10118967B2 Methods for treating rheumatoid arthritis by administering IL-6 receptor antibodies Chemistry; Metallurgy 8 Active
US8372398B2 Single domain VHH antibodies against Von Willebrand Factor Emerging Cross-Sectional Technologies 8 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.